Thank you again for submitting your work to Molecular Systems Biology. We have now heard back from the three referees who agreed to evaluate your manuscript. As you will see from the reports below, the referees find the topic of your study interesting. They raise, however, several points on your work, which should be addressed in a revision of the study.
The points raised by reviewers #1 and #2 require additional clarifications and discussions. Reviewer #3 requests some additional experimentation. Measurements of the impact of E expression on both growth and lysis rates seems to be achievable. On the other hand, we feel that the generation of a short lived Pamp-GFP reporter to follow in real time the lysis process, while a nice experiment, may not significantly add to the conclusions of the present study and is thus optional. With regard to the third experimental request from reviewer #3--performing experiments with a high BlaM expressing construct (point 3)--the experiments may require more time. Since their outcome may change the (paradoxical) trend seen and lead to more robust conclusions, these additional data appear to be important.
Please note that we strongly encourages authors to upload the 'source data' of figures that show *quantitative measurements*. These files--for example tables of individual numerical values and measurements--are separate from the traditional supplementary information files and are submitted using the "figure source data" option in the tracking system. Source data are directly linked to specific figure panels so that interested readers can directly download the associated 'source data' (see, for example, <http://tinyurl.com/365zpej>), for the purpose of alternative visualization, reanalysis or integration with other data. Additional formatting guidelines for 'source data' are available for download <http://www.nature.com/msb/authors/source-data.pdf>.
If you feel you can satisfactorily deal with these points and those listed by the referees, you may wish to submit a revised version of your manuscript. Please attach a covering letter giving details of the way in which you have handled each of the points raised by the referees. A revised manuscript will be once again subject to review and you probably understand that we can give you no guarantee at this stage that the eventual outcome will be favorable. Review for "Programming stress-induced altruistic death in engineered bacteria" by Ranouchi et al.
This interesting paper applies synthetic biology to investigate a major question in biology: What conditions lead to apparently altruistic behaviors by individual organisms. The model system chosen is programmed cell death in bacteria, where E. coli was engineered for programmed cell death and altruistic release of beta-lactamase (BlaM). The BlaM release upon cell lysis degrades extracellular 6-APA (a beta-lactam antibiotic), the signal that itself triggers cell death. This is a very interesting synthetic biology investigation of the "public good dilemma", although not the first one, where BlaM represents a public good that may be exploited by non-altruistic cells. The results show that a population of cells can, counter-intuitively, grow better with higher concentrations of antibiotic. This explains a 'Eagle effect' with implications for antibiotic treatment of infectious disease. The topic is very interesting, as there is much interest in linking mechanistic insight with ultimate explanations for the evolution of cooperation. However, the paper has major points that should be addressed before publication: Comments -One of the main claims is that the study helps explain the paradoxical 'Eagle effect'. However, the mechanism where death-caused release of cytoplasmic beta-lactamase is completely artificial, an engineered product of synthetic biology. There is no support that "the release of beta-lactamase into environment through cell lysis" is a mechanism to stabilize cell death. If there is evidence for this in other natural bacteria, then those should be cited. But if not then These claims should be omitted.
-The paper ignores recent work of particular relevance here. Most notably, the work on indole production by E.coli and its role in the population level resistance to antibiotics must be discussed (Lee, H. H., M. N. Molla, et al. (2010) . "Bacterial charity work leads to population-wide resistance." Nature 467(7311): 82-85.). Also, the introduction (end of page 3) lists examples where syntheticbiology was applied to evolution but the list is far from exhaustive. It misses many important recent examples. The topic was reviewed in depth in this same journal (Xavier, J. B. (2011) . "Social interaction in synthetic and natural microbial communities." Mol Syst Biol 7). The same reference also provides additional examples of public goods problems in microbiology to complement the table in figure 1.
-A central point made in this paper is that programmed cell death is an altruistic trait. However, the experiments meant to show this central point are not convincing. When the strains PAD and NPD are mixed together, the only results shown are miniaturized plots of flow cytometer histograms of the GFP. Why wasn't mCherry fluorescence measured also? Why wasn't the change in frequency of the PAD and NPD strains quantified from the flow cytometer data? And why not show the results for the swap color experiment (the legend states that the experiments was done)? -In page 4 "We note that the first aspect is evident in the variable GFP expression from the PampC promoter in cells carrying a reporter circuit (Figure 2a )." What variability is this referring to? The variability in the main peak of the population? Or is it the small fraction of cells that keep GFP off (the population is bimodal)? This point must be explained better as the variability in 6-APA-induced cell-wall damage is central.
Reviewer #2 (Remarks to the Author):
This paper provides a fresh look at the well-known but still poorly understood phenomenon of altruistic programmed cell death occurring in response to stress response. This seemingly counterintuitive behavior from the point of view of an individual organism increases the chances for the population survival and therefore beneficial, however the evolutionary mechanism of its selection in the face of competition with "cheaters" is not resolved. Authors employ a combined computational/synthetic biology approach by constructing a dual-module "altruistic death" gene circuit and its computational model. The experimental system is comprised of two separate but connected modules: an earlier-developed "suicide module" that leads to lysis in response to 6-APA antibiotic treatment, and a "public good module" that synthesizes BlaM protein. This protein, after being released in extracellular space, suppresses cell lysis by 6-APA. The detailed and elegant experiments show that after initial transient the strain with altruistic death circuit outperforms the strain without this circuits. The experiments are augmented by the modeling results, and a good qualitative agreement is found between the two. The authors also confirmed the existence of the "Eagle effect" when in a certain parameter range the bacteria with altruistic death circuits grow better when treated with higher levels of antibiotic. This effect is also found in the computational model and therefore obtained a possible mechanistic explanation. As mentioned above, one of the biggest puzzles of the naturally occurring altruistic death systems is how it could emerge in the course of evolution. While the clonal population with the altruistic death system can outperform a clonal population without it, the mixture of the two populations typically favors the strain that does not have the programmed death system. Authors attempted to address this question, however unfortunately they did not find a satisfactory explanation of this apparent contradiction. It would be useful to espouse more on this crucial issue and speculate on the possible solutions.
I still believe that the paper is definitely worth publication in MSB. Using synthetic biology in combination with computational modeling is a promising novel approach that may shed additional light on this interesting problem.
There is a small typo in the model formulation in Supplementary material: X and E denote the same thing, the concentration of E protein. ~ Reviewer #3 (Remarks to the Author):
Referee report on the paper: "Programming stress-induced altruistic death in engineered bacteria Running title: Altruistic death in engineered bacteria" by Tanouchi et al.
Summary of review
I think this is an excellent paper that should be published in MSB, it demonstrates nicely how synthetic biology approaches can allow careful dissection of cooperative systems and bring about some surprising insights, whose relevance to natural systems should be studied. I am sure that this work will serve as a baseline for further work in the field. In the following I describe the work and then ask for some more experimental supplements and modifications to the text, model and data analysis, which I think are well within the reach of this research group.
Summary of work ---------------This manuscript presents a great contribution to the unresolved question of altruistic value of bacterial cell death. Programmed cell death is easy to explain within the framework of multicellular organisms, its occurrence among unicellular organisms however (whether yeast, diflagellate or bacteria) is considered somewhat bizarre as no obvious direct benefits arise for the cell executing death. That's why previous works studied closely the social context of the programmed cell death from the Hamiltonian perspective of inclusive fitness -where the death of single cell while being detrimental for their own fitness, is beneficial for their surrounding population depending on the level of relatedness.
Unlike previous studies, this work tackles the question by by-passing the limitations of native systems in quantitative cost/benefit exploration of programmed cell death and allows for mapping the space of relationship between varying levels of cost (death) and varying levels of benefits. Authors skillfully decouple cell death into two modules -death module which regulates the autolysis of the cell under stress caused by antibiotic and benefit module, which under control of inducible promoter produces different levels of beta-lactamase enzyme. This enzyme posses no benefit for the cell itself and it can provide benefit of being a public good only upon autolysis of the cell producing it and the consequent release of the enzyme to the media. Thus, by independently modulating the parameters of rate of death and the rate of public good production authors map the space when the single cell "suicide" is beneficial for the population at large. The ingenious approach allow them to demonstrate the relatively complex and not very much intuitive interplay between the parameters and the phase when programmed cell death could be advantageous. The authors also present an analytical model which captures some of the essential characteristics of the experimental data. The main findings of the authors are: 1. Cooperative behavior indeed leads to growth advantage in comparison to a non-cooperative strain when separated, but this advantage is highly dependent on the dynamics of the system (time, initial conditions and parameters). 2. In fully mixed populations, non-cooperator invade cooperators by social "cheating", demonstrating the cooperative nature of this process. 3. The tradeoff between the costs and benefits of altruistic death lead to an optimal level of lysis, which depends on the relative levels of benefit to cost. Surprisingly an increase in the production of public goods per cell, leads to an increase in the optimal death-rate. 4. The system display an 'eagle effect': The growth of the population increases in some parameter regimes for an increase in antibiotic dosage. This behavior supposedly depends on the antibioticsinduced lysis of the cells, and is shown to be true also for cells with a periplasmic beta-lactamase.
Summary of requests:
--------------------As mentioned above, I think the paper is very good in its current form, but I still think it can be improved by following at least some of the issues. The main request (by order of difficulty) are given below followed by detailed discussion in the following section 1. Use a high copy plasmid system to express BlaM and repeat the results of Figs. 4,5 with a higher expression levels of the public good. 2. Clone a Pamp-E-GFPlite operon to follow E dynamics in real time. 3. Repeat the death rate measurement and add a growth-rate measurements for varying levels of antibiotics. 4. Repeat the eagle effect measurements for the NPDBla system and for an NPDBla system harboring a 6-APA sensitized mutant. 5. Measure growth-rate in the antibiotics for the wild-type (add to fig 3a) . 6. Rewrite the section on optimal lysis rate (p. 8) 7. Write an analytical treatment of the equations. 8. Analyze the system in terms of Cost and Benefit. 9. Various other small changes I would especially think that points 1,3 should be done on the experimental side. The theoretical or writing modifications are all easy to follow.
Analysis of work ----------------1. While being written very well, the introduction is omitting some of the prime examples of bacterial cell death -bacteriocins and skf module from B. subtilis. While bacteriocins are known for decades, and the autolysis is in fact part of the mechanism of their release, even current works studying the social context of their release is not mentioned (Gardner et al, 2004) . The fact that they are generally episomaly encoded "suicide" modules does not warrant their exclusion when programmed cell death is discussed. Similarly, work related to the production of the extracellular killing factor Skf is not mentioned, probably due to the fact that here the death is caused by external factor without autolysis, however at the level of the clonal population, this is still considered to be a programmed cell death of the phenotypically distinct subpopulation with the cost payed by the lysed cells and benefit enjoyed by the population (works of Losick and Kolter labs). Figure 1a should be modified accordingly. It may also be useful to refer to two recent reviews linking systems biology with social behavior (Xavier, MSB, 2011) and probabilistic differentiation ( Reuven and Eldar, Curr. Op. in Dev. And Gen., 2011).
Cost of E expression:
Both in discussion and model, the authors describe the cost of the system as emerging from the altruistic death of some cells. However, the expression of the E gene may lead to two effects -First and as noted; it will lead to lysis of some cells. Second -it may reduce the growth rate of the viable cells (see e.g . Maratea et al, gene, 1985) . Expressing the lysis system in nonlysing cells is therefore a source of cost that brings no benefit (same goes for expressing the public goods gene in these cells). In a natural system one would expect this unnecessary cost to be minimized by a bistability mechanism upstream of the lysis module. Indeed, it was shown that the colK toxin gene (and presumably the lysis gene, but not the immunity gene) is expressed in a bistable OFF/ON manner in the population (Mule et al, J. bact, 2003) .
In this respect, the authors utilize time lapse to calculate the effect of antibiotic on lysis rate for the intial level of antibiotics. In my view, the authors should measure both the lysis rate and growth rate of the PAD and NPD systems. This should be done for a range of antibiotics concentration, not only the initial level, as E expression is tightly coupled to antibiotics levels.
Additionally, it might be useful to have a construct that expresses both the E gene and a short lived GFP under the control of the Pamp promoter. This would allow the authors to follow the lysis process (or a proxy of it) in real time during the evolution process. To my knowledge, people have been using fluorescein-6-APA in the past to measure directly the degradation of 6-APA -I am not sure this material is commercially available.
Production of public goods and the optimization of lysis rate
The authors find experimentally that the optimal rate of lysis actually increases with an increase in the production of public good. This is counter-intuitive, as we would expect that given a higher level of BlaM production, the same level of public goods can be maintained with reduced lysis, thereby reducing the cost of the system. The authors manage to find a parameter regime in their model which shows this behavior.
The change in the optimal death rate of the system is fairly small compared to observed experimental difference. Also, the phenomena observed in the model seems to be very sensitive to parameters (like time of observation) and results mostly from the extremely flat behavior of the system at high production of public goods. In fact, it looks like the experimental results are far more robust than the modeling results. This weakness is reflected in the paragraphs describing the phenomena (p. 8) are very confusing and unconvincing.
I have few questions and requests regarding this point: a. Can the authors show the experimental graphs also for earlier and later times, to see whether this change in optimum is robust or not? b. A better description of the phenomena is required. I think the text in its current form is too confusing.
c. Benefit to cost ratio: Finally and most importantly, it looks like the trend of the optimum is reversed for high enough BlaM expression. In this regard, I am puzzled by the decision of the authors to express the BlaM public good gene from a medium copy plasmid (pPROLar.A122). This most likely reduces the amount of public goods that can be made per cell. I suggest that the authors will reproduce the experimental and modeling results with a new BlaM expression vector based on a high copy number plasmid and higher total expression levels (probably a factor of 3-5 more BlaM protein per cell). My guess is that this will lead to changes in the experimental results that will make them more intuitive. This is probably the most experimentally daunting request I have, as it requires cloning and re-calibration of the system, but it does not require anything which is beyond the means of this very talented research group.
Eagle effect
The eagle effect described by the authors and the fact that it works also for periplasmic betalactamase are very interesting. I have a comment, a question and a request: a. Eagle effect has been observed in 4-quilonons whose resistance mode of action does not depend on a public good (or semi-public good) such as antibiotics degradation, but on changes to the target and efflux. b. The eagle effect observed by the authors is obviously density dependent. Is there any knowledge whether the eagle effect that has been observed in penicillin is density dependent?
c. If the authors observe the phenomena in PADBla cells, why wouldn't they observe it in the wildtype? It might be that wild-typ lysis is not sufficiently high for this effect. In this case, I suggest using a mutant sensitized to 6-APA without the death module (e.g, AcrB of the quoted Nagano & Nikaido paper). I do not think this is a must for publication, but if that works it will definitely make the paper more attractive.
Modeling:
I think that one would get an intuitive grasp of the model using analytical tools for some important limits. Basically, the system can be divided into three timescales (not two, as the authors suggest). (a) Initially, cells respond to the antibiotics by altruistic death governed by the lysis time-scale. (b) Once most (e.g half) of the cells have lysed, the levels of beta-lactamase in the medium will remain approximately constant and antibiotics levels will go down linearly with time, following the zeroorder kinetics of enzymatic degradation. (c) Once antibiotics levels passes a the threshold where growth dominates over the death (mostly from natural death at this point if the E gene has stopped being induced) the cells switch to growth which is governed by the growth-rate timescale.
I simulated the normalized equations of the authors and the three different time-scales are apparent if one consider strong lysis (high beta1) -one can clearly see the initial accumulation of betalactamase followed by a linear decrease in the levels of antibiotics. The lysis and degradation timescales are more similar with parameters corresponding to low lysis rate, implying that antibiotics levels go down with a second-order decrease.
I think the authors should add an approximate analytical treatment to their supp info, comparing the dynamical behavior of all relevant variables (beta-lactamase accumulation, antibiotic degradation, growth and lysis) in the simulation with the approximate analytical results, and seeing which of their insights (optimum lysis rate, eagle effect) can be grasped by the analytical treatment.
A small interesting point to consider from a theoretical perspective is the optimal regulation of the E gene by the antibiotics. I would claim that one wants this regulation to be non-linear for the following reasons: at the beginning of the process, one wants a strong response to the antibiotics, so substantial amount of public goods would be made. When cell density goes down, one wants to quickly reduce this lysis rate to prevent the associated reduction in cell number (which is now unnecessary). This claim is based on intuition rather than on strict analysis -it is also not extremely important -but maybe the authors would like to develop it further.
A minor typo: The authors use E instead of X in the feedback loop term in the equation for X.
6. Social evolution framework: the competition between the PAD and NPD strain demonstrate the sensitivity to exploitation of the cooperative system. The adaptive dynamics analysis done by the authors demonstrate that for the parameters chosen by the authors for the model (and presumably for the experimental system) the level of relatedness of the cells is required to be fairly high, implying a benefit to cost ratio not dramatically higher than 1.
In this regard, it will be nice if the authors will frame their results in the language of costs and benefits used in social evolution literature. Of course, this dynamical system is complex leading to non-linear an complex relations between cost, benefit and frequency of cooperators. A similar exercise was done by Chuang et al (MSB, 2010) and would be worthwhile repeating here.
It will also be interesting to repeat the analysis for the high-copy plasmid strain I suggest constructing in section 3 above, where benefit to cost ratio is probably higher.
Several minor issues:
a. Antibiotic levels -there is no mention what is the MIC of 6-APA. I think it would be insightful to put the growth curve of the wild-type (no lysis and no public good) in the medium together with that of the PAD and NPD strains in Fig. 3a .
b. Figure 3d (and others) -the PAD system is at a low constant OD for low IPTG levels -this is probably an artifact of the measuring device (plate reader) which cannot read below a certain OD. Can the authors get another estimate for the shape of the curve below this OD?
Reviewer #1:
This interesting paper applies synthetic biology to investigate amajor question in biology: What conditions lead to apparently altruistic behaviors by individual organisms. The model system chosen is programmed cell death in bacteria, where E. coli was engineered for programmed cell death and altruistic release of beta-lactamase (BlaM). The BlaM release upon cell lysis degrades extracellular 6-APA (a beta-lactam antibiotic), the signal that itself triggers cell death. This is a very interesting synthetic biology investigation of the "public good dilemma", although not the first one, where BlaM represents a public good that may be exploited by non-altruistic cells. The results show that a population of cells can, counterintuitively, grow better with higher concentrations of antibiotic. This explains a 'Eagle effect' with implications for antibiotic treatment of infectious disease. The topic is very interesting, as there is much interest in linking mechanistic insight with ultimate explanations for the evolution of cooperation.
We thank the reviewer for recognizing the significance of our study and for providing insightful comments.
One of the main claims is that the study helps explain the paradoxical 'Eagle effect'. However, the mechanism where death-caused release of cytoplasmic beta-lactamase is completely artificial, an engineered product of synthetic biology. There is no support that "the release of beta-lactamase into environment through cell lysis" is a mechanism to stabilize cell death. If there is evidence for this in other natural bacteria, then those should be cited. But if not then these claims should be omitted.
The purpose of our synthetic system is to capture the basic logic of altruistic death and study the conditions where programmed death becomes advantageous. We summarized in Fig. 1a several examples of what is believed to be death-mediated public good in nature, and believe that our findings can be applied to these natural systems. By capturing the common logic of these diverse systems, our synthetic circuits have provided quantitative insights into the conditions under which altruistic death becomes advantageous at the population level. In addition, we found that the death-mediated public-good release could cause the Eagle effect, a paradoxical phenomenon where increasing antibiotic dose enhances bacterial growth. We note that some bacterial pathogens (Livermore, 1995) can indeed express low levels of beta-lactamase. It is possible that, when treated by beta-lactam antibiotics, these bacteria could exhibit Eagle effect. However, we do acknowledge that (also in the original submission), whether the Eagle effect reported in the literature is indeed due to altruistic death remains to be elucidated.
Referernce:
Livermore DM (1995) beta-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 8: 557-584
The paper ignores recent work of particular relevance here. Most notably, the work on indole production by E.coli and its role in the population level resistance to antibiotics must be discussed (Lee, H. H., M. N. Molla, et al. (2010) . "Bacterial charity work leads to population-wide resistance." Nature 467(7311): 82-85.). Also, the introduction (end of page 3) lists examples where synthetic-biology was applied to evolution but the list is far from exhaustive. It misses many important recent examples. The topic was reviewed in depth in this same journal (Xavier, J. B. (2011) . "Social interaction in synthetic and natural microbial communities." Mol Syst Biol 7). The same reference also provides additional examples of public goods problems in microbiology to complement the table in figure 1.
We thank the reviewer for pointing out these relevant and important references. We have now cited and discussed the suggested studies in our revised text.
A central point made in this paper is that programmed cell death is an altruistic trait. However, the experiments meant to show this central point are not convincing. When the strains PAD and NPD are mixed together, the only results shown are miniaturized plots of flow cytometer histograms of the GFP. Why wasn't mCherry fluorescence measured also? Why wasn't the change in frequency of the PAD and NPD strains quantified from the flow cytometer data? And why not show the results for the swap color experiment (the legend states that the experiments was done)?
We thank the reviewer for the suggestion on our data analysis and presentation. GFP and mCherry were used to distinguish PAD and NPD strains under the microscope ( Figure S1 ). To measure the frequency of PAD strain in a mixed culture in a highthroughput manner, we chose to use flow cytometry. The flow cytometer used for this study is not equipped with a laser and filter set for mCherry fluorescence, and thus we only measured GFP. However, GFP measurement is sufficient for us to distinguish the two subpopulations in a mixture. To further support our point, we have also carried out the experiment with switched reporters, which we have now included in Figure  S2d (as suggested by the reviewer). We have also quantified the fraction of each strain and included the results in each panel.
In page 4 "We note that the first aspect is evident in the variable GFP expression from the PampC promoter in cells carrying a reporter circuit (Figure 2a )." What variability is this referring to? The variability in the main peak of the population? Or is it the small fraction of cells that keep GFP off (the population is bimodal)? This point must be explained better as the variability in 6-APA-induced cell-wall damage is central.
We meant the variability in the main peak as this suggests that E gene expression from P ampC promoter is also variable. We have clarified this point in the text.
Reviewer #2:
This paper provides a fresh look at the well-known but still poorly understood phenomenon of altruistic programmed cell death occurring in response to stress response… I still believe that the paper is definitely worth publication in MSB. Using synthetic biology in combination with computational modeling is a promising novel approach that may shed additional light on this interesting problem.
We thank the reviewer for recognizing the significance of the research topic and the novelty of our approach.
As mentioned above, one of the biggest puzzles of the naturally occurring altruistic death systems is how it could emerge in the course of evolution. While the clonal population with the altruistic death system can outperform a clonal population without it, the mixture of the two populations typically favors the strain that does not have the programmed death system. Authors attempted to address this question, however unfortunately they did not find a satisfactory explanation of this apparent contradiction. It would be useful to espouse more on this crucial issue and speculate on the possible solutions.
We thank the reviewer for the suggestion. In the discussion session, we previously mentioned two general solutions to the 'public-good dilemma', high level of assortment (either by population bottleneck or spatial structure) and pleiotropy. We have now expanded this section and included the discussion on the regulation of altruistic death. In natural systems, programmed death may be regulated by cell density and/or a bistable mechanism where phenotypically distinct dying and nondying subpopulations are generated. Such regulations may also help evolution of altruistic death.
There is a small typo in the model formulation in Supplementary material: X and E denote the same thing, the concentration of E protein.
We thank the reviewer for pointing out the typo. We have now fixed it.
Reviewer #3:
I think this is an excellent paper that should be published in MSB, it demonstrates nicely how synthetic biology approaches can allow careful dissection of cooperative systems and bring about some surprising insights, whose relevance to natural systems should be studied. I am sure that this work will serve as a baseline for further work in the field. In the following I describe the work and then ask for some more experimental supplements and modifications to the text, model and data analysis, which I think are well within the reach of this research group This manuscript presents a great contribution to the unresolved question of altruistic value of bacterial cell death. Programmed cell death is easy to explain within the framework of multicellular organisms, its occurrence among unicellular organisms however (whether yeast, diflagellate or bacteria) is considered somewhat bizarre as no obvious direct benefits arise for the cell executing death. That's why previous works studied closely the social context of the programmed cell death from the Hamiltonian perspective of inclusive fitness -where the death of single cell while being detrimental for their own fitness, is beneficial for their surrounding population depending on the level of relatedness.
Unlike previous studies, this work tackles the question by by-passing the limitations of native systems in quantitative cost/benefit exploration of programmed cell death and allows for mapping the space of relationship between varying levels of cost (death) and varying levels of benefits. Authors skillfully decouple cell death into two modules -death module which regulates the autolysis of the cell under stress caused by antibiotic and benefit module, which under control of inducible promoter produces different levels of beta-lactamase enzyme. This enzyme posses no benefit for the cell itself and it can provide benefit of being a public good only upon autolysis of the cell producing it and the consequent release of the enzyme to the media. Thus, by independently modulating the parameters of rate of death and the rate of public good production authors map the space when the single cell "suicide" is beneficial for the population at large. The ingenious approach allow them to demonstrate the relatively complex and not very much intuitive interplay between the parameters and the phase when programmed cell death could be advantageous.
1. While being written very well, the introduction is omitting some of the prime examples of bacterial cell death -bacteriocins and skf module from B. subtilis. While bacteriocins are known for decades, and the autolysis is in fact part of the mechanism of their release, even current works studying the social context of their release is not mentioned (Gardner et al, 2004) . The fact that they are generally episomaly encoded "suicide" modules does not warrant their exclusion when programmed cell death is discussed. Similarly, work related to the production of the extracellular killing factor Skf is not mentioned, probably due to the fact that here the death is caused by external factor without autolysis, however at the level of the clonal population, this is still considered to be a programmed cell death of the phenotypically distinct subpopulation with the cost payed by the lysed cells and benefit enjoyed by the population (works of Losick and Kolter labs). Figure 1a should be modified accordingly. It may also be useful to refer to two recent reviews linking systems biology with social behavior (Xavier, MSB, 2011) and probabilistic differentiation ( Reuven and Eldar, Curr. Op. in Dev. And Gen., 2011) .
We thank the reviewer for suggesting relevant and important references. We have now included these studies in the text (Introduction and Discussion) and Fig. 1a. 2. Cost of E expression: …Both in discussion and model, the authors describe the cost of the system as emerging from the altruistic death of some cells. However, the expression of the E gene may lead to two effects -First and as noted; it will lead to lysis of some cells. Second -it may reduce the growth rate of the viable cells (see e.g. Maratea et al, gene, 1985) . …In this respect, the authors utilize time lapse to calculate the effect of antibiotic on lysis rate for the intial level of antibiotics. In my view, the authors should measure both the lysis rate and growth rate of the PAD and NPD systems. This should be done for a range of antibiotics concentration, not only the initial level, as E expression is tightly coupled to antibiotics levels.
These were indeed the questions we contemplated upon. In light of the reviewer's comment, we have performed additional time-lapse microscopy ( Figure S1d, e ) similar to what was done in Fig. S1a-c . Based on our experience, PAD cells hardly divide at 100 µg/ml 6-APA or higher, so we decided to use lower 6-APA concentrations. For all 6-APA concentrations tested (12.5, 25, and 50 µg/ml), the time to first division did not significantly differ between NPD and PAD cells. This may be due to asynchronous cell cycle in the population and the adaptation to the new growth environment (e.g. from liquid phase to solid phase). In contrast, subsequent divisions took longer for PAD cells, suggesting that E gene expression indeed slowed down cell division. Also, in the presence of 6-APA, the fraction of cells that lysed before the first division was always higher for PAD cells, consistent with the killing effect of E protein. Furthermore, our result suggests that the fraction of lysed cells increased as 6-APA concentration was increased, consistent with Figure  5a .
While these additional experimental results indeed suggest growth inhibition by E protein, this effect is minor compared with its lysis effect. As for the modeling analysis, including the growth inhibition by E protein does not alter our conclusions. As such, we prefer to keep the model as it is for simplicity (in the sense that the growth inhibition is not critical to generate the experimentally observed phenomena). If the reviewer still thinks that including the growth effect is more appropriate, however, we would be happy to include results from the additional analysis (with growth inhibition by E protein taken into account).
We thank the reviewer the suggestion and we agree that tracking E gene expression, lysis dynamics, and 6-APA degradation is a very interesting aspect, as it would provide insight into the biophysical process of E-mediated cell lysis. We believe that this will serve as a foundation for future study.
3. Production of public goods and the optimization of lysis rate a. Can the authors show the experimental graphs also for earlier and later times, to see whether this change in optimum is robust or not?
In Figure S6c (previously Figure S5b) , we showed the temporal dynamics of the optimality. There was no optimality in the initial phase (2-6h); but the optimality became evident during 18-24h. During this time window, the optimal death rate robustly increased as public-good production increased. These observations are fully consistent with model predictions. b. A better description of the phenomena is required. I think the text in its current form is too confusing.
We have revised the text to clarify this point.
c. Benefit to cost ratio: Finally and most importantly, it looks like the trend of the optimum is reversed for high enough BlaM expression. In this regard, I am puzzled by the decision of the authors to express the BlaM public good gene from a medium copy plasmid (pPROLar.A122). This most likely reduces the amount of public goods that can be made per cell. I suggest that the authors will reproduce the experimental and modeling results with a new BlaM expression vector based on a high copy number plasmid and higher total expression levels (probably a factor of 3-5 more BlaM protein per cell). My guess is that this will lead to changes in the experimental results that will make them more intuitive. This is probably the most experimentally daunting request I have, as it requires cloning and recalibration of the system, but it does not require anything which is beyond the means of this very talented research group.
We thank the reviewer for the acute observation. We should note that the dominant effect of increasing the rate of public-good expression and release is the overall elevation of growth for all variants of PAD cells. That is, with further increase in public-good production rate, the cell density overall increase significantly for different values of E synthesis rate (β 1 ). As a result, the model predicts that the dependence of final cell density on β 1 becomes flat at high public-good production rates (Figure 4a, inset) . As such, even though the optimal death rate is predicted to decrease, the numerical difference between cell densities at different β 1 (>0) values is small.
In light of reviewer's comment, we cloned a version of pBlaM on a high copy number plasmid (ColE1, Cm R ). We observed that this construct resulted in significantly slower cell growth, requiring substantial re-calibration of the system. Therefore, we decided to increase the public-good production by adding 0.02% L(+)-arabinose in the growth media, which is shown to increase the transcription rate from a P lac/ara-1 promoter significantly (Lutz & Bujard, 1997) . The arabinose did not significantly alter the basal growth rate, and thus the experiment was performed in the same way as before.
As shown in Figure S6b , increasing IPTG from 0.031 mM to 0.25 mM increased the optimal death rate. Further increase in public-good production (0.5 and 1 mM IPTG) indeed resulted in a very flat landscape, consistent with the model prediction, (Figure 4a ). This flatness of the landscape makes it difficult to identify the optimal death rate experimentally although this flatting effect indicates that the fitness seems to have increased more for those with lower lysis (e.g. from 0.13 mM to 1 mM), which is consistent with the idea that the optimality shifted toward lower lysis rate. 4. Eagle effect The eagle effect described by the authors and the fact that it works also for periplasmic betalactamase are very interesting. I have a comment, a question and a request: b. The eagle effect observed by the authors is obviously density dependent. Is there any knowledge whether the eagle effect that has been observed in penicillin is density dependent?
We are grateful that the reviewer pointed out this interesting aspect. To our knowledge, it is not known if the Eagle effect observed with beta-lactam antibiotics is density dependent; it would be interesting to revisit previous cases of Eagle effect with penicillin and test for their density dependence.
c. If the authors observe the phenomena in PADBla cells, why wouldn't they observe it in the wild-type? It might be that wild-typ lysis is not sufficiently high for this effect. In this case, I suggest using a mutant sensitized to 6-APA without the death module (e.g, AcrB of the quoted Nagano & Nikaido paper). I do not think this is a must for publication, but if that works it will definitely make the paper more attractive.
When we repeated the experiment in Figure 7 with NPDBla strain (NPD but pBlaM is replaced with pBla) we did not observe the Eagle effect. The basic logic for the Eagle effect is a negative feedback in the system: antibiotic-mediated cell lysis can lead to faster antibiotic degradation, and potentially faster population recovery. However, having this negative feedback does not guarantee the Eagle effect. It is a complex and dynamical feature of the system dependent on various parameters. As such, more systematic analysis is required to see if wild-type cells expressing Bla (or other beta-lactamase) can give rise to the Eagle effect. Using the suggested mutant is certainly a promising candidate although we did not have this strain in the lab. Other important factors may include growth condition and antibiotics. We are also interested in this question and planning to pursue it as a part of future research.
Modeling:
I think that one would get an intuitive grasp of the model using analytical tools for some important limits. Basically, the system can be divided into three timescales (not two, as the authors suggest). (a) Initially, cells respond to the antibiotics by altruistic death governed by the lysis time-scale. (b) Once most (e.g half) of the cells have lysed, the levels of betalactamase in the medium will remain approximately constant and antibiotics levels will go down linearly with time, following the zero-order kinetics of enzymatic degradation. (c) Once antibiotics levels passes a the threshold where growth dominates over the death (mostly from natural death at this point if the E gene has stopped being induced) the cells switch to growth which is governed by the growth-rate timescale.
For the parameter sets we used for our simulations, the E protein level is typically below 1 even for the largest beta1 used. As such, the lysis dynamics is sensitive to both the cell density and E protein level, making it a second-order dynamics. This makes the suggested analysis non-trivial. For example, although assuming an initial high antibiotic level (and thus constant cell growth rate and E protein synthesis rate) makes E protein dynamics linear and allows for analytical expression of the population dynamics (n(τ)), obtaining a closed-form, analytical expression for the time when the population density drops to a certain level (e.g. half of the initial condition) is challenging because n(τ) is in the form of (n 0 is the initial cell density, and p, q, and r are combinations of the system parameters). In this respect, we believe that our numerical simulations have already provided significant insights such as an optimal lysis rate and the Eagle effect.
A small interesting point to consider from a theoretical perspective is the optimal regulation of the E gene by the antibiotics. I would claim that one wants this regulation to be nonlinear for the following reasons: at the beginning of the process, one wants a strong response to the antibiotics, so substantial amount of public goods would be made. When cell density goes down, one wants to quickly reduce this lysis rate to prevent the associated reduction in cell number (which is now unnecessary). This claim is based on intuition rather than on strict analysis -it is also not extremely important -but maybe the authors would like to develop it further. This is indeed an interesting point. We implemented a simple mechanism to realize the density control where E protein synthesis rate (beta1) becomes 0 when the cell density is below a threshold level (n c ). n c =0 means that there is no density control whereas E protein is never expressed when n c =1. Our simulation supports the reviewer's intuition (figure below); with an appropriate n c value, the cell growth at the final time point was indeed improved, suggesting the benefit of density control. Actually, we have been looking at the benefit of quorum sensing (a type of densitydependent control) in regulating public-good production in a separate study. Figure: PAD growth with a density control. E protein synthesis rate becomes 0 when the cell density is below a threshold value n c . n c =0 means that there is no density control whereas E protein is never expressed when n c =1 (the same as NPD). With an appropriate n c value, the cell growth at the final time point was indeed improved, suggesting the benefit of density control. β 1 = 0.05, β 2 = 4, a(0) = 5.5, and n(0) = 0.2 were used.
We thank the reviewer for pointing out the typo. We have corrected it. 6. Social evolution framework: …In this regard, it will be nice if the authors will frame their results in the language of costs and benefits used in social evolution literature. Of course, this dynamical system is complex leading to non-linear an complex relations between cost, benefit and frequency of cooperators. A similar exercise was done by Chuang et al (MSB, 2010) and would be worthwhile repeating here. It will also be interesting to repeat the analysis for the high-copy plasmid strain I suggest constructing in section 3 above, where benefit to cost ratio is probably higher.
In social evolution literature, the condition for altruistic traits to be favored is often described by Hamilton's rule, 1 , where b, c, and r are benefit, cost, and relatedness, respectively. The study by Chuang et al (MSB, 2010) illustrated how to connect the terms in Hamilton's rule with experimental manipulations. To this end, we simulated a competition of NPD (β 1 = 0) and PAD (β 1 > 0) with a simple population structure. We found that for a given β 1 for PAD, PAD can only outcompete NPD under a narrow range of β 2 (Figure S9 ). This is very similar to what was observed in the Chuang's study where an apparent increase in the "absolute benefit" disfavored altruistic trait. It was shown in their analysis that the increase in absolute benefit may not necessarily increase b in Hamilton's rule. Following their analysis, we also examined how the parameter b and c change as β 2 changes. We found that b and c have a biphasic dependence on β 2 , making the effect of β 2 (system parameter) on competition of the two strains (evolutionary dynamics) non-trivial ( Figure S9 ). We have now incorporated this additional analysis.
Several minor issues:
We have added a growth curve of NPD without IPTG to Figure 3a .
b. Figure 3d (and others) -the PAD system is at a low constant OD for low IPTG levelsthis is probably an artifact of the measuring device (plate reader) which cannot read below a certain OD. Can the authors get another estimate for the shape of the curve below this OD?
For the IPTG-dependence of PAD strain in Figure 3d , we diluted the cultures at 24 th hour 100-fold into fresh media, and observed their growth for additional 24 hours ( Figure S4 ). Based on their growth dynamics, we see overall that the lower the IPTG, the lower the final cell density although for lower IPTG concentrations (0, 0.031, 0.063, and 0. 13 mM) the growth was very variable, probably due to the very low cell density and the additional 100-fold dilution. Thank you again for submitting your work to Molecular Systems Biology. We are now globally satisfied with the modifications made and we are pleased to inform you that we will be able to accept your paper for publication pending the following minor points:
-As you will see below, reviewer #3 makes some final suggestions for possible clarifications and amendments and we would kindly ask you to incorporate these modification in the text.
-We would be grateful if you could add a I am in general very satisfied with the author's response to my comments and recommend accepting the paper in its current form. Below are two short comments. I do not see a reason to review the paper again even if the authors wish to make small changes based on these comments.
1. E gene effect on growth rate: a. The data clearly demonstrate that the effect is small. Actually, I am not sure why the effect is statistically significant where the authors claim it is (12.5 ug.ml) -are they showing standard deviation instead of standard error?
b. The data indicate that the levels of 6-APA sufficient for full activation of the E gene are around 50ug/ml (compare Figs S1b with S1e). Might be worth mentioning this somewhere in the text.
c. In any case, I do not see any reason to modify the model to include this obviously weak effect.
2. Figure 4 : I still think the explanation given by the authors in the main text to the results shown in fig 4b,c are a bit vague. Specifically: a. why would the growth rate of the fast-death strain be higher in the recovery phase than the 'slowdeath'? If antibiotic is fully removed then both should grow at the same rate?
b. Why would the change from death to recovery phase occur at the same time in a given condition for both strains? It doesn't really look like that in Fig 4b. I think that the text should explain why the fast-death strain has a higher growth rate in the recovery phase. Also, showing the graph of the antibiotic levels, growth rates and death rates as a function of time for the two strains and two conditions (in the supp info) might illuminate this issue further.
2nd Revision -authors' response 02 October 2012
We thank reviewer #3 for his final comments and suggestions. According to these, we have further revised the manuscript and incorporated additional simulation results. Below are our point-by-point responses to the reviewerís comments.
Reviewer #3:
1. E gene effect on growth rate:
a. The data clearly demonstrate that the effect is small. Actually, I am not sure why the effect is statistically significant where the authors claim it is (12.5 ug.ml) -are they showing standard deviation instead of standard error?
Yes, the error bars indicate standard deviation. We have clarified this point in the figure legend.
We thank the reviewer for this suggestion. Although the fraction of lysis (the proportion of cells that underwent lysis before first division with respect to the initial number of cells) appeared to be similar between 50 and 400 µg/ml 6-APA, the former allowed significant number of cell divisions while the latter did not. Therefore, our data suggest that 50 µg/ml 6-APA was likely insufficient for full activation of the E gene. But further studies are needed to draw definitive conclusions.
As suggested by the reviewer, we decided to keep the current model. Figure 4 : I still think the explanation given by the authors in the main text to the results shown in fig 4b,c are a bit vague. Specifically: a. why would the growth rate of the fast-death strain be higher in the recovery phase than the 'slowdeath'? If antibiotic is fully removed then both should grow at the same rate?
2.
Antibiotic degradation is actually faster for the fast-death case. We have included an additional figure (Fig. S5c ) and revised the text to clarify this point.
b. Why would the change from death to recovery phase occur at the same time in a given condition for both strains? It doesn't really look like that in Fig 4b. In Fig 4b and c , we meant to show death and recovery phases for the fast-death strain. As the reviewer pointed out, the slow-and fast-death strains have different timing at which the growth switches from death to recovery phase. We have clarified this in the figure legend.
I think that the text should explain why the fast-death strain has a higher growth rate in the recovery phase. Also, showing the graph of the antibiotic levels, growth rates and death rates as a function of time for the two strains and two conditions (in the supp info) might illuminate this issue further.
We thank the reviewer for this excellent suggestion. We have included a figure showing the dynamics of antibiotic level and net cell growth rate (i.e. growth rate minus death rate) in Fig. S5b and revised the main text accordingly.
